• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“我们是引擎”:一项与欧洲罕见先天性畸形和/或智力残疾患者倡导者进行的关于临床实践指南制定的焦点小组研究。

'We are the engine': a focus group study on clinical practice guideline development with European patient advocates for rare congenital malformations and/or intellectual disability.

作者信息

Klein Haneveld Mirthe Jasmijn, de Mortier Chloé Aymée, Hugon Anne, Cornel Martina Cornelia, Gaasterland Charlotte Maria Wilhelmina, van Eeghen Agnies Marguerite

机构信息

Amsterdam UMC, University of Amsterdam, Emma Children's Hospital, Meibergdreef 9, Amsterdam, The Netherlands.

European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA, Clinical Genetics Department, Robert Debré University Hospital, 48 Boulevard Serurier, 75935, Paris, France.

出版信息

Orphanet J Rare Dis. 2025 Apr 10;20(1):169. doi: 10.1186/s13023-025-03673-9.

DOI:10.1186/s13023-025-03673-9
PMID:40205602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11983842/
Abstract

BACKGROUND

Individuals living with rare congenital malformations and/or intellectual disability often face challenges in accessing appropriate healthcare. Clinical practice guidelines (CPGs) may serve as a tool to provide evidence-based care for rare diseases, but their development is complex, and the views of affected individuals and families often remain unknown.

METHODS

Patient advocates of the European Reference Network ITHACA (Intellectual disability, TeleHealth, Autism and Congenital Anomalies) participated in focus groups in which their experiences with and perspectives on CPG use and development were discussed.

RESULTS

Patient advocates considered CPGs relevant to address information and care needs and support advocacy efforts. Important characteristics included representation of heterogeneity within conditions, a holistic approach in which and how topics are addressed, user-friendly availability for individuals and families, and reliability of information. Guideline development and implementation were described as challenging, iterative processes in which effective partnership between clinicians, patient advocates, and other stakeholders is essential.

CONCLUSIONS

Understanding the perspectives of patient advocates is essential to develop CPGs that meet the life-long and complex care needs of individuals and families living with rare conditions. Identified challenges include balancing the urgency of information needs with thorough guideline development processes, as well as the integration and interpretation of different types of knowledge.

摘要

背景

患有罕见先天性畸形和/或智力残疾的个体在获得适当医疗保健方面往往面临挑战。临床实践指南(CPG)可作为为罕见疾病提供循证护理的工具,但其制定过程复杂,受影响个体和家庭的观点往往不为人知。

方法

欧洲参考网络ITHACA(智力残疾、远程医疗、自闭症和先天性异常)的患者倡导者参加了焦点小组,讨论了他们在CPG使用和制定方面的经验及观点。

结果

患者倡导者认为CPG与满足信息和护理需求以及支持宣传努力相关。重要特征包括疾病内异质性的体现、处理主题的方式和方法的整体方法、对个人和家庭友好的可用性以及信息的可靠性。指南的制定和实施被描述为具有挑战性的迭代过程,其中临床医生、患者倡导者和其他利益相关者之间的有效合作至关重要。

结论

了解患者倡导者的观点对于制定满足患有罕见疾病的个体和家庭终身复杂护理需求的CPG至关重要。已确定的挑战包括在信息需求的紧迫性与全面的指南制定过程之间取得平衡,以及不同类型知识的整合和解读。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f43d/11983842/2e97835e7c6e/13023_2025_3673_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f43d/11983842/082656deded6/13023_2025_3673_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f43d/11983842/aaaa6d4359e2/13023_2025_3673_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f43d/11983842/b41c116d0f24/13023_2025_3673_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f43d/11983842/2e97835e7c6e/13023_2025_3673_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f43d/11983842/082656deded6/13023_2025_3673_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f43d/11983842/aaaa6d4359e2/13023_2025_3673_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f43d/11983842/b41c116d0f24/13023_2025_3673_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f43d/11983842/2e97835e7c6e/13023_2025_3673_Fig4_HTML.jpg

相似文献

1
'We are the engine': a focus group study on clinical practice guideline development with European patient advocates for rare congenital malformations and/or intellectual disability.“我们是引擎”:一项与欧洲罕见先天性畸形和/或智力残疾患者倡导者进行的关于临床实践指南制定的焦点小组研究。
Orphanet J Rare Dis. 2025 Apr 10;20(1):169. doi: 10.1186/s13023-025-03673-9.
2
Priority-setting criteria for clinical practice guideline development on rare genetic neurodevelopmental disorders: a Delphi study within the European Reference Network ITHACA.罕见遗传性神经发育障碍临床实践指南制定的优先级设定标准:欧洲参考网络ITHACA内的一项德尔菲研究
J Clin Epidemiol. 2025 Mar 18;182:111761. doi: 10.1016/j.jclinepi.2025.111761.
3
Improving care for rare genetic neurodevelopmental disorders: A systematic review and critical appraisal of clinical practice guidelines using AGREE II.改善罕见遗传性神经发育障碍的护理:使用AGREE II对临床实践指南进行系统评价和批判性评估。
Genet Med. 2024 Apr;26(4):101071. doi: 10.1016/j.gim.2024.101071. Epub 2024 Jan 12.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
Telemedicine strategy of the European Reference Network ITHACA for the diagnosis and management of patients with rare developmental disorders.欧洲参考网络 ITHACA 用于罕见发育障碍患者诊断和管理的远程医疗策略。
Orphanet J Rare Dis. 2020 Apr 25;15(1):103. doi: 10.1186/s13023-020-1349-1.
6
'Mind the Gap'-A Survey on Care Gaps and Priorities for the Transition to Adult Healthcare According to Caregivers of Young People With Rare Conditions Associated With Intellectual Disability.“留意差距”——针对与智力残疾相关的罕见病青年患者照料者对向成人医疗保健过渡中的照料差距及优先事项的调查
J Intellect Disabil Res. 2025 Mar 14;69(6):480-8. doi: 10.1111/jir.13229.
7
Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability.胎儿丙戊酸谱系障碍患者的诊断和管理;先天性畸形和智力残疾欧洲参考网络的共识声明。
Orphanet J Rare Dis. 2019 Jul 19;14(1):180. doi: 10.1186/s13023-019-1064-y.
8
Care needs of chronically ill patients with intellectual disabilities in Dutch general practice: patients' and providers' perspectives.荷兰全科医疗中慢性智力残疾患者的护理需求:患者和提供者的观点。
BMC Health Serv Res. 2024 Jun 14;24(1):732. doi: 10.1186/s12913-024-11155-0.
9
Fostering Shared Decision-Making Between Patients and Health Care Professionals in Clinical Practice Guidelines: Protocol for a Project to Develop and Test a Tool for Guideline Developers.在临床实践指南中促进患者和医疗保健专业人员之间的共享决策:为指南制定者开发和测试工具的项目的方案。
JMIR Res Protoc. 2024 Nov 4;13:e57611. doi: 10.2196/57611.
10
Designing rare disease care pathways in the Republic of Ireland: a co-operative model.爱尔兰共和国罕见病护理路径的设计:一种合作模式。
Orphanet J Rare Dis. 2022 Apr 11;17(1):162. doi: 10.1186/s13023-022-02309-6.

本文引用的文献

1
Enhancing Equitable Access to Rare Disease Diagnosis and Treatment around the World: A Review of Evidence, Policies, and Challenges.加强全球罕见病诊断和治疗的公平可及性:证据、政策和挑战综述。
Int J Environ Res Public Health. 2023 Mar 8;20(6):4732. doi: 10.3390/ijerph20064732.
2
Patient and public involvement in the development of clinical practice guidelines: a scoping review.患者和公众参与临床实践指南制定:范围综述。
BMJ Open. 2022 Sep 28;12(9):e055428. doi: 10.1136/bmjopen-2021-055428.
3
Advancing qualitative rare disease research methodology: a comparison of virtual and in-person focus group formats.
推进定性罕见病研究方法学:虚拟与面对面焦点小组形式的比较。
Orphanet J Rare Dis. 2022 Sep 11;17(1):354. doi: 10.1186/s13023-022-02522-3.
4
Enhancing patient and public contribution in health outcome selection during clinical guideline development: an ethnographic study.在临床指南制定过程中增强患者和公众对健康结局选择的参与:一项民族志研究。
BMC Health Serv Res. 2022 Mar 18;22(1):361. doi: 10.1186/s12913-022-07736-6.
5
Rare, epilepsy-related disorder including intellectual disability - A scoping review of caregivers' identified information needs.罕见的、与癫痫相关的疾病,包括智力残疾 - 对照顾者确定的信息需求的范围综述。
J Intellect Disabil. 2022 Sep;26(3):704-717. doi: 10.1177/17446295211002348. Epub 2021 May 17.
6
Clinical guidelines and the pursuit of reducing epistemic uncertainty. An ethnographic study of guideline development panels in three countries.临床指南与减少认识不确定性的追求。对三个国家指南制定小组的民族志研究。
Soc Sci Med. 2021 Mar;272:113702. doi: 10.1016/j.socscimed.2021.113702. Epub 2021 Jan 15.
7
Exploring approaches to identify, incorporate and report patient preferences in clinical guidelines: Qualitative interviews with guideline developers.探索在临床指南中识别、纳入和报告患者偏好的方法:对指南制定者的定性访谈。
Patient Educ Couns. 2021 Apr;104(4):703-708. doi: 10.1016/j.pec.2020.10.001. Epub 2020 Oct 7.
8
Involving People with Learning Disabilities in Guideline Development.让学习障碍者参与指南制定。
Patient. 2020 Apr;13(2):251-254. doi: 10.1007/s40271-019-00390-x.
9
Policies and actions to tackle rare diseases at European level.欧洲层面解决罕见病的政策和行动。
Ann Ist Super Sanita. 2019 Jul-Sep;55(3):296-304. doi: 10.4415/ANN_19_03_17.
10
Integrating patient perspectives in medical decision-making: a qualitative interview study examining potentials within the rare disease information exchange process in practice.将患者观点融入医疗决策中:一项定性访谈研究,旨在探讨实践中罕见病信息交流过程中的潜力。
BMC Med Inform Decis Mak. 2019 Sep 18;19(1):188. doi: 10.1186/s12911-019-0911-z.